The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk
Ferrara M, Umlauf A, Sanders C, Meyer JM, McCutchan J, Duarte N, Atkinson J, Grant I, Ellis RJ, Group T. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk. Psychiatry Research 2014, 218: 201-208. PMID: 24794030, PMCID: PMC4082695, DOI: 10.1016/j.psychres.2014.04.015.Peer-Reviewed Original ResearchConceptsSecond-generation antipsychoticsBody mass indexAntiretroviral therapyCardiovascular riskMultivariable modelExact testUse of SGAsHIV Neurobehavioral Research ProgramLong-term antiretroviral therapyHigher body mass indexHigher mean triglyceridesMetabolic syndrome componentsHuman immunodeficiency virusDiabetes mellitus incidenceLogistic multivariable modelFisher's exact testMean triglyceridesMetabolic complicationsHIV diseaseSerum lipidsSyndrome componentsArterial pressureMedication combinationsMass indexImmunodeficiency virus